IgG's exceptional structural stability is an exploitable advantage
- IgG antibodies feature 12+ disulfide bonds and rigid β-sheet architecture providing exceptional stability.
- Caprylic acid at pH 4.5-5.0 destabilizes host cell proteins through hydrophobic core disruption while antibodies remain soluble.
- This differential stability—exploited by plasma fractionation for 70+ years—transfers directly to recombinant antibodies.
- The chemistry is 70+ years proven in plasma fractionation.
- Brodsky et al.
- validated transfer to CHO antibodies.
- The challenge is molecule-specific optimization and regulatory strategy, not fundamental science.
Is this for a new product/biosimilar or an approved product requiring process change? New products have clearer regulatory pathways for novel purification chemistry. Approved products may benefit more from incremental high-capacity resin improvements while developing precipitation platform for next molecule.
Caprylic Acid Precipitation + Single Polish
Transfer 70-year proven plasma chemistry to CHO antibodies. 55-70% cost reduction expected. What needs to be solved: molecule-specific aggregation screening.
High-Capacity Protein A with Enhanced Clarification
MabSelect PrismA (70-80 g/L DBC) with polyelectrolyte flocculation. 40-55% cost reduction. What needs to be solved: process integration.
- Execute caprylic acid precipitation screening immediately—$30-50K experiment answers key question within 4-6 weeks.
- Plasma fractionation industry has employed this approach for 70 years; Brodsky's 2012 publication proves viability for CHO antibodies.
- Primary risk centers on molecule-specific aggregation; you'll know within one month whether your antibody tolerates conditions.
- Concurrently implement high-capacity resin + flocculation optimization as near-term win.
- This represents best-practice catch-up—not innovative, but low-risk, delivering 40-50% savings within 6-12 months while developing precipitation platform.
- For longer term, seriously evaluate chromatography-free precipitation train for next new product or biosimilar.
- Dairy industry purifies IgG at $2-5/kg using only precipitation.
- Regulatory acceptance of this approach in antibodies fundamentally reshapes biologics manufacturing economics.
- Elastin-like polypeptide and crystallization approaches, while intellectually elegant, require excessive upstream engineering or molecule-specific optimization for near-term impact.
- Maintain radar positioning for next-generation platform development.